Syndecan-1 is up-regulated in ras-transformed intestinal epithelial cells

被引:7
|
作者
Wong, ZM
Choo, B
Li, M
Carey, DJ
Cano-Gauci, DF
Buick, RN
机构
[1] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada
[3] Sigfried & Janet Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA
基金
英国医学研究理事会;
关键词
proteoglycan; syndecan; ras transformation; intestinal epithelial cell;
D O I
10.1038/bjc.1998.147
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The syndecans, a family of cell-surface heparan sulphate proteoglycans, have been proposed to mediate cellular interactions with extracellular effector molecules, such as growth factors and components of the extracellular matrix, during critical phases of development. Transcripts of all four syndecans are expressed at varying levels in the developing rat intestine and in a series of immature rat intestinal epithelial cell lines, In addition, we report the novel finding that, in the intestinal epithelial cell lines, expression of syndecan-1 transcript is up-regulated by transformation with activated H-ras. This is in contrast to other cell lines in which ras transformation is associated with a decrease in syndecan-1 levels. The observed increase in the syndecan-1 occurs as a result of increased transcription and can be correlated with the degree of transformation of the IEC-18 cells. Transformation is also associated with a decrease in apparent molecular weight and increased shedding of the proteoglycan into the culture medium. Increased shedding of syndecan-1 into the culture medium after transformation with H-ras may contribute to the disruption of proteoglycan interactions with the extracellular matrix, leading to alterations in cell adhesion and organization.
引用
收藏
页码:890 / 896
页数:7
相关论文
共 50 条
  • [1] Syndecan-1 is up-regulated in ras-transformed intestinal epithelial cells
    ZM Wong
    B Choo
    M Li
    DJ Carey
    DF Cano-Gauci
    RN Buick
    British Journal of Cancer, 1998, 77 : 890 - 896
  • [2] Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers
    Conejo, JR
    Kleeff, J
    Koliopanos, A
    Matsuda, K
    Zhu, ZW
    Goecke, H
    Bicheng, N
    Zimmermann, A
    Korc, M
    Friess, H
    Büchler, MW
    INTERNATIONAL JOURNAL OF CANCER, 2000, 88 (01) : 12 - 20
  • [3] Restoration of sensitivity to anoikis in Ras-transformed rat intestinal epithelial cells by a Ras inhibitor
    Shalom-Feuerstein, R
    Lindenboim, L
    Stein, R
    Cox, AD
    Kloog, Y
    CELL DEATH AND DIFFERENTIATION, 2004, 11 (02): : 244 - 247
  • [4] Restoration of sensitivity to anoikis in Ras-transformed rat intestinal epithelial cells by a Ras inhibitor
    R Shalom-Feuerstein
    L Lindenboim
    R Stein
    A D Cox
    Y Kloog
    Cell Death & Differentiation, 2004, 11 : 244 - 247
  • [5] TRANSLATIONAL SUPPRESSION OF SYNDECAN-1 EXPRESSION IN HA-RAS TRANSFORMED MOUSE MAMMARY EPITHELIAL-CELLS
    KIRJAVAINEN, J
    LEPPA, S
    HYNES, NE
    JALKANEN, M
    MOLECULAR BIOLOGY OF THE CELL, 1993, 4 (08) : 849 - 858
  • [6] Differential regulation of cyclooxygenase-2 in nontransformed and ras-transformed intestinal epithelial cells
    Du, JG
    Jiang, B
    Barnard, J
    NEOPLASIA, 2005, 7 (08): : 761 - 770
  • [7] ALTERED ADHESIONS IN RAS-TRANSFORMED BREAST EPITHELIAL-CELLS
    KINCH, MS
    BURRIDGE, K
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (03) : 446 - 450
  • [8] Growth inhibitory signalling by TGFβ is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus
    Jiang, B
    Zhang, JS
    Du, JG
    Urrutia, R
    Barnard, J
    CELLULAR SIGNALLING, 2003, 15 (07) : 699 - 708
  • [9] Image analysis of the AgNOR response in ras-transformed human breast epithelial cells
    Mello, Maria Luiza S.
    Vidal, Benedicto C.
    Russo, Jose
    Planding, Wolfgang
    Schenck, Ulrich
    ACTA HISTOCHEMICA, 2008, 110 (03) : 210 - 216
  • [10] Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells
    Matesic, DF
    Villio, KN
    Folse, SL
    Garcia, EL
    Cutler, SJ
    Cutler, HG
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (06) : 741 - 754